(Q42546403)

2 November 2017

title

Antinociceptive activity of sodium valproate in mice after chronic treatment (English)

1 reference

2 November 2017

Abulaban FS

1

1 reference

2 November 2017

Dhariwal MA

series ordinal

2

1 reference

2 November 2017

al-Bekairi AM

series ordinal

3

1 reference

2 November 2017

Raza M

series ordinal

4

1 reference

2 November 2017

publication date

1 September 1997

1 reference

2 November 2017

1 reference

2 November 2017

volume

29

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

463-467

1 reference

Established anticonvulsants and treatment of refractory epilepsy

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Mechanism of anticonvulsant action of valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Distribution of valproate across the interface between blood and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Central analgesic effect of valproate in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

A Controlled Study of the Effect of Sodium Valproate on Photosensitive Epilepsy and Its Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Valproic acid: reversibly acting drug?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Plasma levels of valproic acid and its metabolites during continued treatment in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

[Action of dipropylacetic acid upon photosensitive Papio papio]

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

The Delayed Effect of Sodium Valproate on the Photoconvulsive Response in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Effect of n-dipropylacetate on amino acid concentrations in mouse brain: correlations with anti-convulsant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Effect of sodium n-dipropylacetate on audiogenic seizures and brain -aminobutyric acid level.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Valproate: a new drug in migraine prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

Positive response to oral divalproex sodium (Depakote) in patients with spasticity and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900471-5

7 January 2021

10.1016/S0306-3623(96)00471-5

Identifiers

DOI

1 reference

2 November 2017

1 reference